Virginia
J&J settles with West Virginia on opioid litigation for $99 mln
The Johnson & Johnson logo design is presented on a display on the flooring of the New York Supply Exchange (NYSE) in New York City, U.S., Might 29, 2019. REUTERS/Brendan McDermid/File Image
April 18 (Reuters) – Johnson & Johnson (JNJ.N) claimed on Monday it had actually consented to pay $99 million to clear up opioid-related insurance claims by the state of West Virginia as well as its class.
The negotiation gets rid of the firm from a recurring test that started previously this month in Kanawha Region Circuit Court. West Virginia is still seeking insurance claims versus Teva Pharmaceuticals Industries Ltd (TEVA.TA), as well as AbbVie Inc’s (ABBV.N) Allergan.
J&J did not confess obligation or misbehavior in the negotiation, the firm claimed.
Register currently totally free limitless accessibility to Reuters.com
Coverage by Manas Mishra in Bengaluru; Modifying by Devika Syamnath
Our Specifications: The Thomson Reuters Depend On Concepts.